Compare · COSM vs ESYN
COSM vs ESYN
Side-by-side comparison of Cosmos Health Inc. (COSM) and EnerSyn Global Inc. (ESYN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COSM and ESYN operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- ESYN is the larger of the two at $48.5M, about 1.6x COSM ($30.2M).
- COSM has hit the wire 9 times in the past 4 weeks while ESYN has been quiet.
- Company
- Cosmos Health Inc.
- EnerSyn Global Inc.
- Price
- -
- -
- Market cap
- $30.2M
- $48.5M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- News (4w)
- 9
- 0
- Recent ratings
- 0
- 0
Cosmos Health Inc.
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products through its distribution channels and e-commerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece, and the United Kingdom; and warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is based in Chicago, Illinois.
EnerSyn Global Inc.
Previously known as HWH International Inc., the Company operates as a purpose-driven lifestyle company encompassing differentiated offerings to develop new pathways to help people in their pursuit of Health, Wealth and Happiness. The Company's management team has begun to evaluate a range of additional growth and investment opportunities that it believes can build long-term shareholder value and drive strong, sustainable growth. The Company intends to pursue such opportunities selectively and prudently, in a manner management deems beneficial to, and aligned with the long-term interests of its stockholders. The Company believes that energy represents a new addition to the Company that may provide favorable opportunities.
Latest COSM
- Cosmos Health's CosmoFarm Begins Commissioning New Automated Order-Processing and Vehicle-Loading Infrastructure, Advancing Capacity That Could Support Over $120 Million in Annual Revenue
- Cosmos Health's Amazon UK Business Surpasses $2 Million in TTM Sales, Up 90%, with a 23% Net Profit Margin; Expects Sales to Grow Approximately 72% to $3.9 Million Over the Next Twelve Months
- SEC Form SCHEDULE 13G filed by Cosmos Health Inc.
- Cosmos Health's U.S. Active Subscriptions Surpass 12,000, Up 92% in Two Weeks
- Noble Capital Markets Initiates Equity Research Coverage on Cosmos Health with Outperform Rating and $1.40 Price Target
- Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway
- SEC Form 8-K filed by Cosmos Health Inc.
- Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion
- Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days
- Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription
Latest ESYN
No recent items for EnerSyn Global Inc..